Cargando…
Clear cell adenocarcinoma of female urethra: A case report
Primary malignancies of the female urethra are rare, accounting for less than 1% of genitourinary malignancies. Clear cell adenocarcinoma of the urethra (CCAU) occurs more infrequently, accounting for 0.003% of malignancies of the female urogenital tract. Definitive clinical diagnosis of CCAU is dif...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991334/ https://www.ncbi.nlm.nih.gov/pubmed/29888186 http://dx.doi.org/10.1016/j.eucr.2018.04.008 |
_version_ | 1783329793911029760 |
---|---|
author | Hartman, Kasondra Li, Jinghong Garg, Tullika |
author_facet | Hartman, Kasondra Li, Jinghong Garg, Tullika |
author_sort | Hartman, Kasondra |
collection | PubMed |
description | Primary malignancies of the female urethra are rare, accounting for less than 1% of genitourinary malignancies. Clear cell adenocarcinoma of the urethra (CCAU) occurs more infrequently, accounting for 0.003% of malignancies of the female urogenital tract. Definitive clinical diagnosis of CCAU is difficult and must be differentiated from tumors of the vagina. Currently, there is limited understanding of the causes of CCAU and there is no established standard of care for treatment. Immunohistochemistry and pathologic analysis can be used to identify the origin of the tumor. |
format | Online Article Text |
id | pubmed-5991334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-59913342018-06-08 Clear cell adenocarcinoma of female urethra: A case report Hartman, Kasondra Li, Jinghong Garg, Tullika Urol Case Rep Oncology Primary malignancies of the female urethra are rare, accounting for less than 1% of genitourinary malignancies. Clear cell adenocarcinoma of the urethra (CCAU) occurs more infrequently, accounting for 0.003% of malignancies of the female urogenital tract. Definitive clinical diagnosis of CCAU is difficult and must be differentiated from tumors of the vagina. Currently, there is limited understanding of the causes of CCAU and there is no established standard of care for treatment. Immunohistochemistry and pathologic analysis can be used to identify the origin of the tumor. Elsevier 2018-05-07 /pmc/articles/PMC5991334/ /pubmed/29888186 http://dx.doi.org/10.1016/j.eucr.2018.04.008 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Oncology Hartman, Kasondra Li, Jinghong Garg, Tullika Clear cell adenocarcinoma of female urethra: A case report |
title | Clear cell adenocarcinoma of female urethra: A case report |
title_full | Clear cell adenocarcinoma of female urethra: A case report |
title_fullStr | Clear cell adenocarcinoma of female urethra: A case report |
title_full_unstemmed | Clear cell adenocarcinoma of female urethra: A case report |
title_short | Clear cell adenocarcinoma of female urethra: A case report |
title_sort | clear cell adenocarcinoma of female urethra: a case report |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991334/ https://www.ncbi.nlm.nih.gov/pubmed/29888186 http://dx.doi.org/10.1016/j.eucr.2018.04.008 |
work_keys_str_mv | AT hartmankasondra clearcelladenocarcinomaoffemaleurethraacasereport AT lijinghong clearcelladenocarcinomaoffemaleurethraacasereport AT gargtullika clearcelladenocarcinomaoffemaleurethraacasereport |